The estimated Net Worth of Jonathan Griggs is at least 70.3 千$ dollars as of 31 May 2017. Mr. Griggs owns over 8,000 units of Cumberland Pharmaceuticals stock worth over 14,585$ and over the last 14 years he sold CPIX stock worth over 55,760$. In addition, he makes 0$ as Independent Director at Cumberland Pharmaceuticals.
Jonathan has made over 2 trades of the Cumberland Pharmaceuticals stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 8,000 units of CPIX stock worth 55,760$ on 31 May 2017.
The largest trade he's ever made was selling 8,000 units of Cumberland Pharmaceuticals stock on 31 May 2017 worth over 55,760$. On average, Jonathan trades about 580 units every 51 days since 2010. As of 31 May 2017 he still owns at least 10,803 units of Cumberland Pharmaceuticals stock.
You can see the complete history of Mr. Griggs stock trades at the bottom of the page.
Jonathan I. Griggs serves as Independent Director of the Company. has served as a member of our Board of Directors since 2010. His career spans more than 41 years in the pharmaceutical and biotechnology industries and includes significant international experience. He spent 23 years at Warner Lambert Corporation in positions of increasing responsibility, culminating with his position as Vice President of Human Resources. During his tenure with Warner Lambert, he provided leadership for the successful integration of three pharmaceutical businesses into what became Parke Davis, the largest consolidation in the industry at that time. From 1992 to present he has been the CEO of Griggs & Associates, a management and human resources consulting firm assisting start-up companies and providing critical assistance in turnaround situations. Mr. Griggs also provided the leadership and strategic management for the formation and establishment of the AACA (Antique Auto Club of America) Museum, a leading transportation museum where he served as chairman and is currently a director. Mr. Griggs has his B.S. Degree from Penn State and attended the Wharton School of Management at the University of Pennsylvania. He has been an advisor to Cumberland Pharmaceuticals as a member of the company’s Pharmaceutical Advisory Board since it began operations in 1999. The Board of Directors believes Mr. Griggs’ experience in strategic management and human resources consulting will be critical as the company continues to build a strong, effective management team.
Jonathan Griggs is 85, he's been the Independent Director of Cumberland Pharmaceuticals since 2010. There are no older and 19 younger executives at Cumberland Pharmaceuticals.
Jonathan's mailing address filed with the SEC is 2525 WEST END AVENUE, SUITE 950, NASHVILLE, TN, 37203.
Over the last 15 years, insiders at Cumberland Pharmaceuticals have traded over 4,393,644$ worth of Cumberland Pharmaceuticals stock and bought 265,077 units worth 1,208,228$ . The most active insiders traders include Joey A Jacobs、Leo Pavliv、Thomas R Lawrence. On average, Cumberland Pharmaceuticals executives and independent directors trade stock every 29 days with the average trade being worth of 10,407$. The most recent stock trade was executed by Caroline Young on 1 December 2022, trading 379 units of CPIX stock currently worth 849$.
cumberland pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. cumberland is dedicated to providing high quality products which address unmet medical needs.
Cumberland Pharmaceuticals executives and other stock owners filed with the SEC include: